3M will invest $146 million dollars to expand its capabilities to further support biotech manufacturing. The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe. The new investment will accelerate 3M’s development and delivery of vital filtration equipment designed for bioprocessing, biological and small molecule pharmaceutical manufacturing applications, which will enable biotech customers to co...